This document provides information on EarWays Medical, a company seeking funding from PARNASA 61 - Biomedical Fund. EarWays has developed earwax removal products for both professionals and home use that use a flexible tip design. The company has over 150 successful uses of its products, is in discussions with distributors and manufacturers, and is working to finalize designs and undergo clinical studies. It is seeking $1 million to fund further product development, clinical studies, business development and marketing.
- Intervyo is an automated interviewing system that screens candidates for recruiters and predicts their suitability for jobs. It was founded in 2014 in Israel.
- It uses artificial intelligence and machine learning to conduct video interviews and analyze candidates' responses, facial expressions, and other attributes to provide a suitability score within 24 hours.
- This allows recruiters to save over 80% of time spent screening candidates and increases hiring accuracy over human recruiters alone.
This document summarizes an investment fund called Parnasa 62 - Tech Fund. It was established in January 2016 to invest in early-stage technology companies based in Israel and the US. The fund has raised $500,000 so far and aims to raise a total of $3.496 million. It will make seed and early-stage investments in startups focused on mobile platforms, education technology, and caregiving. The management team has extensive experience in startups, venture capital, and business development.
This document provides information on EarWays Medical, a company seeking funding from PARNASA 61 - Biomedical Fund. EarWays has developed earwax removal products for both professionals and home use that use a flexible tip design. The company has over 150 successful uses of its products, is in discussions with distributors and manufacturers, and is working to finalize designs and undergo clinical studies. It is seeking $1 million to fund further product development, clinical studies, business development and marketing.
This document provides information on JettaPlus, an online marketplace for unused plane tickets. It discusses JettaPlus' mission to become a leading marketplace for €50 plane tickets. It outlines how JettaPlus launched in Israel in 2016 and became a competitive player with over 1 million visitors and 1000 ticket sales totaling over $250,000. The document also discusses opportunities in the airline industry with increasing travelers and unused tickets each year, as well as JettaPlus' experience working with airlines, travel companies, and insurance companies. Financial projections show JettaPlus requesting $6 million in funding to launch in May 2018 and continue growing through June 2019.
This document provides an overview of S.B. Group Ltd., an Israeli company that develops innovative solutions to enhance quality of life for seniors. The company specializes in products that help with daily living tasks like putting on socks. The Sockee and Stockeez products assist those with mobility issues in independently putting on and taking off socks and medical compression stockings. The company is seeking funding to expand its product line and sales in markets like the US, EU, Israel, and Australia. It has patents, manufacturing capabilities, and distribution agreements to facilitate growth goals of increasing monthly sales over the next year.
Filterlex Medical develops an embolic protection device to reduce stroke risk during heart procedures. It aims to raise $1.715 million for its next-generation device which uses a collapsible frame and filter pockets to capture and remove embolic particles. The total addressable market for such devices is estimated to reach $2 billion annually, with the transcatheter aortic valve implantation market alone expected to surpass $3.02 billion by 2020. The management team has extensive experience in healthcare, startups, investment, and business development.
EARWAYS MEDICAL is a leading innovator of ear-care solutions. Founded to enhance the well-being of millions of children and adults worldwide, EARWAYS MEDICAL provides easy-to-use ear care products, designed for clinicians and home use.
Jacana is a SaaS platform that uses predictive analytics, big data, and AI to identify passive talent and engage them in the recruiting process to help companies find the best candidates efficiently. Existing recruiting methods are inefficient and costly. Jacana's algorithm analyzes millions of candidates using thousands of data points to identify those most likely to be receptive and a good fit based on the company, position, and manager. The target market is $4 billion growing at 9% annually. Jacana charges subscription fees and has raised pre-seed funding. The management team has extensive experience in recruiting, startups, and business development.
- Intervyo is an automated interviewing system that screens candidates for recruiters and predicts their suitability for jobs. It was founded in 2014 in Israel.
- It uses artificial intelligence and machine learning to conduct video interviews and analyze candidates' responses, facial expressions, and other attributes to provide a suitability score within 24 hours.
- This allows recruiters to save over 80% of time spent screening candidates and increases hiring accuracy over human recruiters alone.
This document summarizes an investment fund called Parnasa 62 - Tech Fund. It was established in January 2016 to invest in early-stage technology companies based in Israel and the US. The fund has raised $500,000 so far and aims to raise a total of $3.496 million. It will make seed and early-stage investments in startups focused on mobile platforms, education technology, and caregiving. The management team has extensive experience in startups, venture capital, and business development.
This document provides information on EarWays Medical, a company seeking funding from PARNASA 61 - Biomedical Fund. EarWays has developed earwax removal products for both professionals and home use that use a flexible tip design. The company has over 150 successful uses of its products, is in discussions with distributors and manufacturers, and is working to finalize designs and undergo clinical studies. It is seeking $1 million to fund further product development, clinical studies, business development and marketing.
This document provides information on JettaPlus, an online marketplace for unused plane tickets. It discusses JettaPlus' mission to become a leading marketplace for €50 plane tickets. It outlines how JettaPlus launched in Israel in 2016 and became a competitive player with over 1 million visitors and 1000 ticket sales totaling over $250,000. The document also discusses opportunities in the airline industry with increasing travelers and unused tickets each year, as well as JettaPlus' experience working with airlines, travel companies, and insurance companies. Financial projections show JettaPlus requesting $6 million in funding to launch in May 2018 and continue growing through June 2019.
This document provides an overview of S.B. Group Ltd., an Israeli company that develops innovative solutions to enhance quality of life for seniors. The company specializes in products that help with daily living tasks like putting on socks. The Sockee and Stockeez products assist those with mobility issues in independently putting on and taking off socks and medical compression stockings. The company is seeking funding to expand its product line and sales in markets like the US, EU, Israel, and Australia. It has patents, manufacturing capabilities, and distribution agreements to facilitate growth goals of increasing monthly sales over the next year.
Filterlex Medical develops an embolic protection device to reduce stroke risk during heart procedures. It aims to raise $1.715 million for its next-generation device which uses a collapsible frame and filter pockets to capture and remove embolic particles. The total addressable market for such devices is estimated to reach $2 billion annually, with the transcatheter aortic valve implantation market alone expected to surpass $3.02 billion by 2020. The management team has extensive experience in healthcare, startups, investment, and business development.
EARWAYS MEDICAL is a leading innovator of ear-care solutions. Founded to enhance the well-being of millions of children and adults worldwide, EARWAYS MEDICAL provides easy-to-use ear care products, designed for clinicians and home use.
Jacana is a SaaS platform that uses predictive analytics, big data, and AI to identify passive talent and engage them in the recruiting process to help companies find the best candidates efficiently. Existing recruiting methods are inefficient and costly. Jacana's algorithm analyzes millions of candidates using thousands of data points to identify those most likely to be receptive and a good fit based on the company, position, and manager. The target market is $4 billion growing at 9% annually. Jacana charges subscription fees and has raised pre-seed funding. The management team has extensive experience in recruiting, startups, and business development.
(2537) MIddle East Invest Summit 2016 A4 17P Brochure 1.55_amendsAlex Augusti
This document provides information about the 17th annual Middle East Investment Summit taking place May 2-3, 2016 in Dubai, UAE. Over 400 investors attend annually to diversify portfolios, maximize returns, and uncover investment opportunities. The summit features over 50 conference sessions on hedge funds, private equity, and real estate across 10 hours of networking. Keynote speakers include institutional investors from sovereign wealth funds, pension funds, and family offices who will discuss topics like portfolio strategies, emerging market opportunities, and industry trends shaping 2016 investments. Early registration discounts are available at the provided website.
The Horizon Group is an executive search and human resources consulting firm founded in 1990 that focuses on fulfilling critical human capital needs for clients. It has expanded over 18 years to serve multiple industries such as capital markets, investment banking, information technology, healthcare, and general administration. The firm prides itself on developing long-term relationships with clients and candidates through its specialized recruiting expertise and commitment to confidentiality, diligence, and strategic networking.
C8I Holdings Limited and its Subsidiaries released its interim financial report for the first half of fiscal year 2016. Some key highlights include:
- Revenue for the period was $22 million with a net profit of $15 million, a significant increase from the previous fiscal year.
- A gain of $9.4 million was realized from the sale of shares in Digimatic Group Ltd.
- A private equity division was formally established to focus on investment deals in private businesses.
- Expansion into China and Malaysia's education markets through new joint ventures and acquisitions.
- Total liquid assets for the company were $44 million as of the reporting period.
Ownership Structure & Venture Capital-B.V.RaghunandanSVS College
Operations of venture capital and private equity and their relevance to Indian economy,as delivered by B.V.Raghunandan in a guest lecture to MBA students of St.Josaeph's Engineering College at Vamanjoor, Mangalore Dt., Karnataka state in India on April 4, 2008
The Rio Tinto staff superannuation fund has over 30,000 members and $5.3 billion in assets. It achieved strong returns of 13.8% in 2013-14 due to its tilt towards growth assets. The fund invests 100% actively managed by selecting several Australian and international equity managers. It focuses on consistent long-term returns over index-beating performance. Member uptake is high at over 90% due to the fund's solid reputation among Rio Tinto employees.
Investors & Opportunities by StartupBashBDStartupBashBD
“Investors & Opportunities” is about connecting investors & entrepreneurs so they can better understand each other’s need within the local context. Sessions will cover stories about successful investments and raising funds along with interactive sessions to put what we’re learning into action
This event was held at NewsCred's office in Dhaka, Bangladesh on November 20, 2013
The document outlines an investment strategy that focuses on identifying "wide-moat compounders" and hidden champions in Asia. It discusses conducting in-depth analysis of companies' business models and corporate culture to protect downside risk while capturing upside potential. The strategy also aims to overcome behavioral biases like the disposition effect by maintaining long-term conviction in high-quality companies even during market volatility.
The document provides descriptions of various diversified financial companies listed on the Australian Securities Exchange (ASX). It describes each company's core business activities which include investment management, funds management, lending, financial planning, stockbroking and more. The companies represent sectors such as investment trusts, investment banking, asset management, and other financial services.
Diversified Financials - Australian Shares ScanShare Trading
Diversified Financials - Australian Shares Scan - Quickly browse through the charts to detect patterns and trends. Great for Technical analysis. Charts shown display 100 MA + 50 EMA and a Custom MACD signal.
Shares Scanned 17th May 2010
Africa AM Asset Management_Africa AM Power 50_31 Aug 14Fatima Sadan, CFA
This document profiles leaders in the African investment management industry. It discusses portfolio managers and fund managers from various firms who are influential in the African markets. It also provides brief biographies on several individuals who manage some of the top performing Africa-focused funds. The document aims to recognize influential figures in the industry and provide information on their experience and roles.
Jacana is a SaaS platform that uses predictive analytics, big data, and AI to identify passive talent and engage them in the recruiting process to help companies find the best candidates efficiently. Existing recruiting methods are inefficient and costly. Jacana's algorithm analyzes millions of candidates using thousands of data points to identify those most likely to be receptive and a good fit based on the company, position, and manager. The target market is $4 billion growing at 9% annually. Jacana charges subscription fees and has raised pre-seed funding. The management team has extensive experience in recruiting, startups, and growing companies.
Andrew Howden is a senior executive with extensive experience in the pharmaceutical industry across Asia, Australia, Europe, and Japan. He has held leadership roles such as CEO, Chairman, and Director for both public and private companies. Howden has a proven track record of developing growth strategies, managing acquisitions, and improving profitability. He currently holds executive positions with First Pharma P/L and The True Origins Company P/L in Australia.
CrossBay Medical was founded to leverage over 50 years of combined experience in the medical device field. Their mission is to develop and manufacture cost-effective medical products and commercialize them globally. They aim to provide affordable healthcare solutions, especially in emerging markets. CrossBay Medical partners with suppliers and innovators to help them obtain regulatory approvals, assess markets, and distribute their products through CrossBay's global network.
The document provides advice and strategies for transformational growth in the pharmaceutical industry. It discusses how the traditional models of blockbuster drugs and generic copies are being disrupted, requiring companies to reinvent themselves. The key strategies suggested include focusing on niche specialty products, branded generics, consumer healthcare, emerging markets, and biotech/diagnostics. The document emphasizes the need to start transforming now through small steps and immediate opportunities. It introduces the advisory team at The Pharma Partners who have deep experience across various areas to help guide strategic transformations.
Ex Assembly - Employee Wellness Programs – Can they Perform in the Spotlight?LearningCafe
The document summarizes a meeting of the EX Assembly community, which is a group of HR and employee experience professionals. The meeting discussed how COVID-19 has impacted employee wellness initiatives and featured presentations from representatives of Allianz, Limeade, and Australian Unity on their approaches to employee experience and wellbeing. Key topics included how organizations have adapted wellness programs during the pandemic, the importance of care and personalization, and challenges in certain sectors like home care workers.
The document provides funding news about several startups that have received investments from Peaceful Progress, a SEBI-registered angel fund. It summarizes the business models and funding amounts for startups like Elevate, a weight loss management platform; Jarsh Safety, which develops industrial safety wearables; EaseMyAI, an automation platform; Evera Cabs, an electric cab service; and SigTuple, which develops AI-based healthcare diagnostic solutions. Peaceful Progress invests in early-stage technology and consumer-led businesses.
nestle International business management slidesaqsaz
The document provides information about Nestle, a Swiss multinational food and drink processing conglomerate. It details that Nestle was founded in 1866 by Henri Nestle and has grown to be the largest food company in the world, present in 191 countries with 447 factories and 339,000 employees. The document also summarizes Nestle's operations, products, strategies, history of growth, and controversies.
Charles Spinosa is the Group Director and Leader of Marketing Practices at VISION. He has helped clients enter difficult markets and find efficiencies in supply chains. The marketing practices at VISION help clients with new products, branding, media integration, and investor relations.
David Walsh is the Chief Executive Officer of Netwatch. He has led the company's growth to 95 employees and a new headquarters building. Netwatch provides security solutions using technologies like GPS tracking and audiovisual detection.
Louise Phelan is the Vice President of Customer Solutions and EMEA Merchant Services at PayPal. She oversees customer service and risk management from PayPal's European center of excellence in Dublin, which employs almost 1,850
The document promotes investment opportunities in life-support areas such as healthcare and agriculture through the Rikas Investment Group. The Group aims to unleash European investment potential in Ukraine by opening an IVF center, managing generic drug supplies, supplying goods to Gaza, and opening dental clinics. It highlights the experience and qualifications of the management team and outlines strategic directions and key investment indicators for the IVF center project.
(2537) MIddle East Invest Summit 2016 A4 17P Brochure 1.55_amendsAlex Augusti
This document provides information about the 17th annual Middle East Investment Summit taking place May 2-3, 2016 in Dubai, UAE. Over 400 investors attend annually to diversify portfolios, maximize returns, and uncover investment opportunities. The summit features over 50 conference sessions on hedge funds, private equity, and real estate across 10 hours of networking. Keynote speakers include institutional investors from sovereign wealth funds, pension funds, and family offices who will discuss topics like portfolio strategies, emerging market opportunities, and industry trends shaping 2016 investments. Early registration discounts are available at the provided website.
The Horizon Group is an executive search and human resources consulting firm founded in 1990 that focuses on fulfilling critical human capital needs for clients. It has expanded over 18 years to serve multiple industries such as capital markets, investment banking, information technology, healthcare, and general administration. The firm prides itself on developing long-term relationships with clients and candidates through its specialized recruiting expertise and commitment to confidentiality, diligence, and strategic networking.
C8I Holdings Limited and its Subsidiaries released its interim financial report for the first half of fiscal year 2016. Some key highlights include:
- Revenue for the period was $22 million with a net profit of $15 million, a significant increase from the previous fiscal year.
- A gain of $9.4 million was realized from the sale of shares in Digimatic Group Ltd.
- A private equity division was formally established to focus on investment deals in private businesses.
- Expansion into China and Malaysia's education markets through new joint ventures and acquisitions.
- Total liquid assets for the company were $44 million as of the reporting period.
Ownership Structure & Venture Capital-B.V.RaghunandanSVS College
Operations of venture capital and private equity and their relevance to Indian economy,as delivered by B.V.Raghunandan in a guest lecture to MBA students of St.Josaeph's Engineering College at Vamanjoor, Mangalore Dt., Karnataka state in India on April 4, 2008
The Rio Tinto staff superannuation fund has over 30,000 members and $5.3 billion in assets. It achieved strong returns of 13.8% in 2013-14 due to its tilt towards growth assets. The fund invests 100% actively managed by selecting several Australian and international equity managers. It focuses on consistent long-term returns over index-beating performance. Member uptake is high at over 90% due to the fund's solid reputation among Rio Tinto employees.
Investors & Opportunities by StartupBashBDStartupBashBD
“Investors & Opportunities” is about connecting investors & entrepreneurs so they can better understand each other’s need within the local context. Sessions will cover stories about successful investments and raising funds along with interactive sessions to put what we’re learning into action
This event was held at NewsCred's office in Dhaka, Bangladesh on November 20, 2013
The document outlines an investment strategy that focuses on identifying "wide-moat compounders" and hidden champions in Asia. It discusses conducting in-depth analysis of companies' business models and corporate culture to protect downside risk while capturing upside potential. The strategy also aims to overcome behavioral biases like the disposition effect by maintaining long-term conviction in high-quality companies even during market volatility.
The document provides descriptions of various diversified financial companies listed on the Australian Securities Exchange (ASX). It describes each company's core business activities which include investment management, funds management, lending, financial planning, stockbroking and more. The companies represent sectors such as investment trusts, investment banking, asset management, and other financial services.
Diversified Financials - Australian Shares ScanShare Trading
Diversified Financials - Australian Shares Scan - Quickly browse through the charts to detect patterns and trends. Great for Technical analysis. Charts shown display 100 MA + 50 EMA and a Custom MACD signal.
Shares Scanned 17th May 2010
Africa AM Asset Management_Africa AM Power 50_31 Aug 14Fatima Sadan, CFA
This document profiles leaders in the African investment management industry. It discusses portfolio managers and fund managers from various firms who are influential in the African markets. It also provides brief biographies on several individuals who manage some of the top performing Africa-focused funds. The document aims to recognize influential figures in the industry and provide information on their experience and roles.
Jacana is a SaaS platform that uses predictive analytics, big data, and AI to identify passive talent and engage them in the recruiting process to help companies find the best candidates efficiently. Existing recruiting methods are inefficient and costly. Jacana's algorithm analyzes millions of candidates using thousands of data points to identify those most likely to be receptive and a good fit based on the company, position, and manager. The target market is $4 billion growing at 9% annually. Jacana charges subscription fees and has raised pre-seed funding. The management team has extensive experience in recruiting, startups, and growing companies.
Andrew Howden is a senior executive with extensive experience in the pharmaceutical industry across Asia, Australia, Europe, and Japan. He has held leadership roles such as CEO, Chairman, and Director for both public and private companies. Howden has a proven track record of developing growth strategies, managing acquisitions, and improving profitability. He currently holds executive positions with First Pharma P/L and The True Origins Company P/L in Australia.
CrossBay Medical was founded to leverage over 50 years of combined experience in the medical device field. Their mission is to develop and manufacture cost-effective medical products and commercialize them globally. They aim to provide affordable healthcare solutions, especially in emerging markets. CrossBay Medical partners with suppliers and innovators to help them obtain regulatory approvals, assess markets, and distribute their products through CrossBay's global network.
The document provides advice and strategies for transformational growth in the pharmaceutical industry. It discusses how the traditional models of blockbuster drugs and generic copies are being disrupted, requiring companies to reinvent themselves. The key strategies suggested include focusing on niche specialty products, branded generics, consumer healthcare, emerging markets, and biotech/diagnostics. The document emphasizes the need to start transforming now through small steps and immediate opportunities. It introduces the advisory team at The Pharma Partners who have deep experience across various areas to help guide strategic transformations.
Ex Assembly - Employee Wellness Programs – Can they Perform in the Spotlight?LearningCafe
The document summarizes a meeting of the EX Assembly community, which is a group of HR and employee experience professionals. The meeting discussed how COVID-19 has impacted employee wellness initiatives and featured presentations from representatives of Allianz, Limeade, and Australian Unity on their approaches to employee experience and wellbeing. Key topics included how organizations have adapted wellness programs during the pandemic, the importance of care and personalization, and challenges in certain sectors like home care workers.
The document provides funding news about several startups that have received investments from Peaceful Progress, a SEBI-registered angel fund. It summarizes the business models and funding amounts for startups like Elevate, a weight loss management platform; Jarsh Safety, which develops industrial safety wearables; EaseMyAI, an automation platform; Evera Cabs, an electric cab service; and SigTuple, which develops AI-based healthcare diagnostic solutions. Peaceful Progress invests in early-stage technology and consumer-led businesses.
nestle International business management slidesaqsaz
The document provides information about Nestle, a Swiss multinational food and drink processing conglomerate. It details that Nestle was founded in 1866 by Henri Nestle and has grown to be the largest food company in the world, present in 191 countries with 447 factories and 339,000 employees. The document also summarizes Nestle's operations, products, strategies, history of growth, and controversies.
Charles Spinosa is the Group Director and Leader of Marketing Practices at VISION. He has helped clients enter difficult markets and find efficiencies in supply chains. The marketing practices at VISION help clients with new products, branding, media integration, and investor relations.
David Walsh is the Chief Executive Officer of Netwatch. He has led the company's growth to 95 employees and a new headquarters building. Netwatch provides security solutions using technologies like GPS tracking and audiovisual detection.
Louise Phelan is the Vice President of Customer Solutions and EMEA Merchant Services at PayPal. She oversees customer service and risk management from PayPal's European center of excellence in Dublin, which employs almost 1,850
The document promotes investment opportunities in life-support areas such as healthcare and agriculture through the Rikas Investment Group. The Group aims to unleash European investment potential in Ukraine by opening an IVF center, managing generic drug supplies, supplying goods to Gaza, and opening dental clinics. It highlights the experience and qualifications of the management team and outlines strategic directions and key investment indicators for the IVF center project.
IN NUTS FUND, a Luxembourg based Investment Fund, the pioneer in innovative and global agriculture strategies, focuses on performing a long-term uncorrelated return through investments in nut production, and processing and distribution companies, mainly locally owned and managed.
This document summarizes Dr. Scott Farrell's presentation on the role universities can play in developing medical technologies. It discusses Dalhousie University's involvement in developing Uresta, a new type of pessary to treat urinary incontinence. The presentation outlines the challenges of translating ideas to products, including funding, regulations, intellectual property, and manufacturing. It describes Dalhousie's support through clinical trials, patenting, business advice, and helping find partners for production and distribution of Uresta.
Grace Century is a research group representing accredited investors, 500+ strong, with a wealth of experience, contacts and insight.
We filter through the 100’s of projects that are brought to us each year and find the true “game changers” that are poised to be the next leader of a new industry or change an existing industry. This usually results in one or two very special projects for consideration a year.
As a group, we are able to negotiate for our members projects obtained from a position of strength, gaining the best possible arrangement, and gaining continuous involvement and oversight as the project develops.
Through this continuous involvement from the top, utilizing our networks in all aspects of business, and offering on-going information, we believe Grace Century gives its members a project with dramatically reduced risk while increasing the probability of success.
Simon C. Lord has over 30 years of global business experience in the life sciences industry. He currently serves as the Director of Marketing and Product Development at MBD Industries, where he has developed 9 new algae-based products and prepared business plans. Prior to this role, Lord held several leadership and marketing roles at BASF and Cognis, where he exceeded sales targets and successfully negotiated new contracts worth over $8 million. Lord has a Graduate Diploma in Biotechnology from the University of Melbourne and a Bachelor of Science with Honors in Biochemistry from Monash University.
This document introduces four individuals who are members of the investment team at IPP Financial Advisers Pte Ltd (IPPFA):
- Albert Lam, Managing Director of IPPFA's Investment Division and chairman of the Investment Committee.
- Tan Lye Poh, Director of Wealth Management at IPPFA and a member of the Investment Committee.
- Eddy Tan, Head of Alternative Investments at IPPFA who assesses alternative investment products.
- David Mok, Head of Fund Management at IPPFA who oversees investment evaluation, selection, and strategy.
This 2005 annual report discusses Baxter's financial performance and innovations. It highlights Baxter's leadership in developing therapies like kidney dialysis and blood component therapy over its 75-year history. In 2005, Baxter introduced many new products, saw strong sales of products like ADVATE for hemophilia, and expanded its contract manufacturing facilities. The report discusses Baxter's strategies for continued growth, including expanding in developing markets and pursuing acquisitions and alliances.
Henry Schein is celebrating its 75th anniversary. It has grown from a small pharmacy founded during the Great Depression to a Fortune 500 company and the largest distributor of healthcare products to office-based practitioners in North America and Europe. Over the years, Henry Schein has expanded through acquisitions, increased its product and service offerings, and provided innovative solutions to help customers run successful practices. Looking to the future, Henry Schein aims to continue growing strategically while preserving its values and commitment to customers, employees, and communities.
Director of Sales - Consumer Heath Care - Strides Shasun INC. USASumesh Pillai
The Director of Sales is responsible for growing Strides' consumer healthcare business in the US, including both branded products and private labels. Key responsibilities include developing and building the branded portfolio, expanding distribution channels and key accounts, managing the national distributor relationship, and providing input into the product pipeline. The role aims to establish Strides as a significant player in the US consumer healthcare market over the next 3-5 years by achieving sales goals and successfully launching new products.
Bienestar Financiero al servicio de su jubilación anticipada
Pago de su 🏡
Estudio de sus hijos
Directamente a tu cuenta bancaria
Con Tesorería Auditoria Jurídica comercial
Administración de carteras
Apalancamiento Financiero
Desarrollo de tu marca personal
Acceso a Desarrollo de varias industrias
Cuentas bancarias
Estructuras Físicas en USA y en América Central
Avalado por Bolcomer
Puesto de Bolsa Comercial
Turismo
Y mucho más
Link de registro
https://business.myinfinity.global/maurod8/
https://therusnetwork.com/
Contacto:
https://goo.su/pzm1fja
UnityNet World Environment Day Abraham Project 2024 Press ReleaseLHelferty
June 12, 2024 UnityNet International (#UNI) World Environment Day Abraham Project 2024 Press Release from Markham / Mississauga, Ontario in the, Greater Tkaronto Bioregion, Canada in the North American Great Lakes Watersheds of North America (Turtle Island).
2. ABOUT US
EarWays Medical is offering solutions for earwax removal and management treatments
both for professional ear care givers and home care users.
The patent pending technology of EarWays Medical uses a flexible tip design to facilitate
ear wax collection with minimal risk. It is easy to use, self-explanatory, and disposable.
The product allows the user to safely remove ear wax from the ear in a safe and effective
manner. It was designed in consultation with ear, nose and throat doctors to ensure safety and
minimize risk to the user.
EarWays Pro and EarWays Homecare are available in several spiral head diameters for
adults, children and toddlers.
PARNASA 61 – Biomedical Fund 2017
3. MISSION
To set the new gold standard in earwax management and
removal, by introducing innovative products for professional
ear care givers and homecare users.
2017PARNASA 61 – Biomedical Fund
4. EarWays Pro - final design stage
EarWays Homecare - advanced design stage
National phase (US, EU, CH, JP, IL) submitted
CE approved
US trade name
Over 150 successful cases
In discussions with Japanese lead player
Signed commitments from Belgian and Israeli distributors
Recruited Scientific Advisory Board
In discussion with hearing aids manufacturer, hearing institutions
Commencing Clinical Study.
2017
HIGHLIGHTS
PARNASA 61 – Biomedical Fund
5. MARKET ANALYSIS
2017PARNASA 61 – Biomedical Fund
USA EarWays
Pro
USA EarWays
Homecare
Europe EarWays
Pro
Europe EarWays
Homecare
$142M
$926M
$389M
$1.667M
Total Addressable Market EU & USA $3B
USA EarWays Pro
USA EarWays Homecare
Europe EarWays Pro
Europe EarWays Homecare
US EUROPE
6. 2017PARNASA 61 – Biomedical Fund
EarWays Pro EarWays Homecare
US TARGET MARKET
7. 10
8
6
4
2
0
2018 2019 2020 2021 2022
FORECASTING
2017
Revenue forecast in US $M
PARNASA 61 – Biomedical Fund
8. $1,700 M
$1,275 M
$850 M
$425 M
$0 M
USA
EarWays Pro
USA EarWays
Homecare
Europe
EarWays Pro
Europe EarWays
Homecare
$3 Billion Total addressable market of Europe
and USA
Entered into partnerships for enhanced distribution
and marketing network
ADDITIONAL INSIGHTS
2017PARNASA 61 – Biomedical Fund
9. Raised to date:
$50K Tnufa - Israeli Office of
Chief Scientist
$100K Self Funding
$100K Angel Investor
$250K Parnasa VC
FUNDINGSEEKING
2017PARNASA 61 – Biomedical Fund
Manufacturing for mass production,
expanded clinical studies, business
development, sales & marketing
$1M
Partnerships; Joint
Ventures; Distribution
Networks
USE OF PROCEEDS
10. Reached
16: EarWays Pro - Finalize design and Clinical Study in Israel
Q1 17:EarWays Pro - Design for Manufacturing and initial sale
Upcoming
Q2 17: EarWays Pro - Limited Market Release EU & US,
EarWays Medical Consumer – Finalize Design for clinical study
Q3 17: EarWays Pro - Launch in EU
EarWays Pro - Limited Market release in the US.
MILESTONES
2017PARNASA 61 – Biomedical Fund
11. THE TEAM
Dr. Kraitzer is an entrepreneur, biomaterials specialist, and
an inventor in the field of medical device.
He has proven record in management and problem solving
skills in both scientific and industrial environments with
extensively experienced engineering capabilities and broad
experience in medical device technology, product
development, manufacturing and commercialization in view
of regulatory requirements (US and European).
2017PARNASA 61 – Biomedical Fund
Dr. Amir Kraitzer
Founder & CTO
12. THE TEAM
2017
Since 2008, Yael has been advising and coaching startups
on their strategy, business development, and fundraising.
She has extensive international experience and expertise
within the startup ecosystem, and holds deep knowledge
of the life science industry.
She managed marketing for a US based startup, giving
her the experience needed to head up the Startup Center
at the Israeli Export Institute and create a technology
matchmaking position at Ernst & Young Israel.
PARNASA 61 – Biomedical Fund
Yael Karlin
Managing Director
13. Offers safe and
effective solution
for home care
users
Has
successfully
covered over
150 cases
Provides high
efficiency even in
hard and complex
cases
Single use device
offering maximal
protection of ear
hygiene
2017
ADVANTAGES
PARNASA 61 – Biomedical Fund
14. Tnufa Israeli Self Funding Angel Investor Parnasa (VC)
$250 K
$200 K
$150 K
$100 K
$50 K
$0 K
Fundingsources
Uses of Proceeds
Manufacturing for mass production
Expanded clinical studies, business development, sales and marketing
2017
FUNDING SOURCES
PARNASA 61 – Biomedical Fund
15. An Israeli company managed by Parnasa Nihul Basad Ltd, seeking to raise $1.715
million in equity capitalization.
The Company’s investment objective is to generate superior long-term capital
appreciation through private equity investments in early-stage private companies
primarily based in the United States and Israel.
The Investment Manager is controlled by Eliezer Gross who holds a controlling interest
of management shares of the Company. The Investment Manager will be responsible
for the Company’s investment strategy and the management of the Company. He will
perform all day-to-day investment and asset management functions for the Company,
subject to the supervision and direction of the Company’s Board of Directors.
The Company has been formed to make seed and early-stage investments in the
common stock and preferred stock of start-up technology ventures located in Israel.
2017
PARNASA 61 - Biomedical Fund
PARNASA 61 – Biomedical Fund
16. INVESTMENT STRATEGYThe Company intends to invest substantially all of the proceeds of the sale of Shares
offered in the existing portfolio.
In addition, the Company may invest (or reinvest proceeds of exited investments) in
one or more other start-up technology ventures from time to time subject to the
availability of resources.
The Company intends to have multiple closings, so that any money that comes in
could immediately be used by the Company even if it is below the total amount of
capital sought to be raised pursuant to the official offering.
2017
INVESTMENT STRATEGY
PARNASA 61 – Biomedical Fund
17. The Company’ s existence is perpetual and therefore
dissolution and/or distribution of all or part of the
Company’s assets are not expected at any
time in the future.
6000 shares = $10,625.
Fund will bear all costs and expenses.
The Company is being treated as a corporation under
the Israeli tax laws.
December 31
25%
FUND
LIFE(TERM):
MINIMUM
PURCHASE:
OFFERING &
ORGANISATION
EXPENSES:
TAXATION:
FISCAL YEAR
END:
CARRIED
INTEREST:
2017
FUND STRUCTURE
PARNASA 61 – Biomedical Fund
18. MANAGEMENT TEAM
2017
MANAGEMENT TEAM
PARNASA 61 – Biomedical Fund
Eliezer Gross,
Founder and Chairman
With over 30 years of experience launching business
ventures in Israel, the United States, and Europe. He was a
founding partner of the American GBM Group, and of the
largest retail chains in Israel. Active in dozens of startup
initiatives and companies worldwide, he knows the U.S
market inside and out and has been influential in developing
many new products.
His keen business acumen has led him through the doors of
dozens of leading companies – primarily from the Fortune
100 including: Johnson & Johnson Corporation, CBS Studios,
Goodyear Tires, et al.
19. MANAGEMENT TEAM
2017
MANAGEMENT TEAM
PARNASA 61 – Biomedical Fund
Cobi Bitton
CEO, Besadno Group
Mr. Bitton is an entrepreneur, organizational consultant, and
expert in business development and the study of entrepreneurial
business models. He holds a Bachelor's degree in Industrial and
Management, an MBA and is highly knowledgeable about
conventional industrial production, environmental issues, and
safety and security products.
He was one of the entrepreneurs and founders of the SEC (Safe
Evacuation Coalition) - an advocacy group formed by companies,
and dedicated to promoting advanced emergency means of
egress solutions in the global market.
He has been counseling businesses, entrepreneurs, startups and
corporations for the past 25 years, empowering clients in the
American, Eastern and Central European, Latin, Russian, and
East Asian markets, among other locations. Cobi serves as the
CEO of Israel - Greece Chamber of Commerce, voluntarily.
20. MANAGEMENT TEAM
2017
MANAGEMENT TEAM
PARNASA 61 – Biomedical Fund
Gabby Hasson
CEO, Bseed Investments
Gabby is the CEO and Co-Founder of Bseed Investments,
with over 25 years of proven experience in the Investment,
IT and cutting-edge technology space in navigating and
uncovering opportunities for excellent growth and
profitability.
Previously, Gabby held management, Investment, and
business development positions, at CB Alliance (VC), IBM,
and HP, as well as Mashik Consulting and CTI. He
specialized in uncovering and enhancing solutions for
Mobile Telecom, Banking, and Online Marketing. Gabby
gained vast experience with IBM's Global Technology Unit
(GTU), that focused on startups and innovations.
21. MANAGEMENT TEAM
2017
MANAGEMENT TEAM
PARNASA 61 – Biomedical Fund
Mr. Eliashiv (LLB) is the Head of Development in the
Besadno Group. Oded has vast experience in the
Israeli startup industry, having led numerous ventures
in leading companies including Excellence Capital
Group (Singapore), Excellence AgriTech Solutions
(Cambodia), Slyde, ElectroPep, Beyond Interactive and
Epos Technologies.
Using his extensive experience in the startup
ecosystem, Oded is now advising early-stage startups
and providing them with the mentoring and fundraising
assistance.Oded Eliashiv
Head of Development,
Besadno Group